dm+d

108406003

Articles

Safety in Lactation: Antimigraine drugs

21 October 2020If simple analgesics, e.g. paracetamol and ibuprofen, are insufficient to treat symptoms, sumatriptan is the drug of choice for the treatment of acute migraine. Although…

What is serotonin syndrome and which medicines cause it?

22 May 2020This Medicines Q&A outlines the causes and symptoms of serotonin syndrome and provides examples of medicines with the potential to cause serotonin syndrome.  

Triptans and SSRI or SNRI antidepressants – is there an interaction?

27 March 2019The likelihood of an interaction between triptans and SSRIs/SNRIs resulting in serotonin syndrome is considered in this updated Medicines Q&A.
Search Articles

Medicine Compliance Aid Stability

ZomigAstraZeneca UK Ltd

AstraZeneca UK Ltd
Zomig
Tablets f/c 2.5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
11 May 2015

Zomig RapimeltAstraZeneca UK Ltd

AstraZeneca UK Ltd
Zomig Rapimelt
Orodispersible tablets 2.5mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Orodispersible tablet so unsuitable for MCA
11 May 2015

Lactation Safety Information

Sumatriptan
No published evidence of safety
5HT1-receptor agonist for treatment of acute migraine
11 August 2020